Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
06/22/2005 | CN1207283C 4-aminopiperidine derivatives and their use as medicine |
06/21/2005 | US6909004 Mixing (2-(((3-methyl-4-(2,2,2-trifluoro-ethoxy)-2-pyridinyl) methyl)sulfinyl)-1H-benzimidazole), with solvents in the presence of amines, then adding acids and isolating the proton pump ihibitor |
06/21/2005 | US6908940 Imidazole compounds and their use as adenosine deaminase inhibitors |
06/21/2005 | US6908938 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
06/21/2005 | US6908936 Respiratory syncytial virus |
06/21/2005 | US6908935 Calcium receptor modulating agents |
06/21/2005 | US6908932 Modulators of phosphoinositide 3-kinase |
06/21/2005 | US6908929 Central nervous system disorders |
06/21/2005 | US6908923 Compositions and methods for treating heart failure |
06/21/2005 | US6908922 Linear cyclic ureas |
06/21/2005 | US6908921 Quinoxalinone derivatives as bradykinin B1 antagonists |
06/21/2005 | US6908920 Pyrimidine derivatives |
06/21/2005 | US6908919 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
06/21/2005 | CA2250372C 6-phenylpyridyl-2-amine derivatives |
06/21/2005 | CA2231143C Farnesyl transferase inhibiting 2-quinolone derivatives |
06/16/2005 | WO2005054430A2 Hepatitis c virus inhibitors |
06/16/2005 | WO2005054278A1 Substituted n-benzyl-lactam derivatives as melanocortin-4 receptor agonists |
06/16/2005 | WO2005054232A1 1-acetic acid-indole, -indazole and-benzimidazole derivatives usful for the treatment of respiratory disorders |
06/16/2005 | WO2005054230A1 Azole-based kinase inhibitors |
06/16/2005 | WO2005054229A1 4-[(arylmethyl)aminomethyl]piperidine derivatives, preparation thereof and application of same in therapeutics |
06/16/2005 | WO2005054228A1 A process for the preparation of substitited pyridinylmethylsulfinyl- benzimidazole enantiomers |
06/16/2005 | WO2005054227A1 (4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics |
06/16/2005 | WO2005054217A1 Developments in biologically active methylene blue derivatives (2) |
06/16/2005 | WO2005054210A1 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
06/16/2005 | WO2005054209A1 7-phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors |
06/16/2005 | WO2005054202A1 7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (proteinkinase b) |
06/16/2005 | WO2005054201A1 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
06/16/2005 | WO2005054199A1 Tubulin inhibitors |
06/16/2005 | WO2005054191A1 Pyrrole compounds |
06/16/2005 | WO2005054179A2 Hydroxamic acid esters and pharmaceutical use thereof |
06/16/2005 | WO2005053663A2 Norepinephrine reuptake inhibitors useful for treatment of cognitive failure |
06/16/2005 | WO2005053628A1 Use of osteopontin in dental formulations |
06/16/2005 | WO2005053610A2 Diamine and iminodiacetic acid hydroxamic acid derivatives |
06/16/2005 | WO2005040150A3 Glutamine fructose-6-phosphate amidotransferase (gfat) inhibitors |
06/16/2005 | WO2005040116A3 Indolinone derivatives and their use in treating disease-states such as cancer |
06/16/2005 | WO2005037832A3 Azabicycyclic compounds for relieving pain and treating central nervous system disorders |
06/16/2005 | WO2005026145A3 Quinolone antibacterial agents |
06/16/2005 | WO2005025293A3 Fused ring heterocycles as potassium channel modulators |
06/16/2005 | WO2005016326A3 Analogs of thalidomide as potential angiogenesis inhibitors |
06/16/2005 | WO2005011592A3 Substituted indazole-o-glucosides |
06/16/2005 | WO2005002552A3 Benzimidazole derivatives and their use as protein kinases inhibitors |
06/16/2005 | WO2004046107A8 Indole derivatives as somatostatin agonists or antagonists |
06/16/2005 | WO2004033436A8 Sulfonylbenzodiazepinone acetamides as bradykinin antagonists |
06/16/2005 | WO1990000853A8 Method of treating neurological disorders |
06/16/2005 | US20050131177 1-Alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators |
06/16/2005 | US20050131050 Reacting ethyl trifluoroacetate with 4'fluoroacetophenone and 4-sulphonamidophenyl hydrazine |
06/16/2005 | US20050131042 HIV protease inhibiting compounds |
06/16/2005 | US20050131041 Using trizole or imidazole compound containing hydroxy group |
06/16/2005 | US20050131032 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors |
06/16/2005 | US20050131026 Bronchitis; chronic obstructive pulmonary disease; antihistamines; pneumonia |
06/16/2005 | US20050131024 Antiinflammatory agents; autoimmune diseases; anticancer agents |
06/16/2005 | US20050131019 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents |
06/16/2005 | US20050131018 Acetylene derivatives as inhibitors of histone deacetylase |
06/16/2005 | US20050131017 HIV protease inhibiting compounds |
06/16/2005 | US20050131016 Chemical compounds |
06/16/2005 | US20050131014 Anticholesterol agents; antidiabetic agents; cardiovascular disorders ; antiarthritic agents |
06/16/2005 | US20050131002 Anticholesterol agents; antilipemic agents; cardiovascular disorders; antiischemic agents; anticancer agents |
06/16/2005 | US20050131001 Anticholesterol agents; antilipemic agents; antiischemic agents; cardiovascular disorders |
06/16/2005 | US20050131000 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity |
06/16/2005 | US20050130998 Central nervous ystem diorders; Alzheimer's disease ; anticancer agents |
06/16/2005 | US20050130989 (3,5-Dimethyl-1-phenyl-1H-pyrazol-4-yl)(4-phenylpiperazin-1-yl)methanone; inhibit tubulin polymerization; cancer |
06/16/2005 | US20050130981 Compounds |
06/16/2005 | US20050130979 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) or the quinoxalinedione is 9-methyl-amino-6-nitro-hexahydro-benzo(F) quinoxalinedione (PNQX) for treating demyelinating disorders |
06/16/2005 | US20050130977 Inhibitors of akt activity |
06/16/2005 | US20050130976 Bicyclic inhibitors of MEK and methods of use thereof |
06/16/2005 | US20050130968 Fungicidal 4-(2-aminopyridin-4-yl)-N-phenyl-1,3,5-triazin-2-amine derivatives |
06/16/2005 | US20050130967 3-Substituted-4-pyrimidone derivatives |
06/16/2005 | US20050130965 Inhibitors of p38 kinase |
06/16/2005 | US20050130953 Pharmacological uses of azetidine derivatives |
06/16/2005 | US20050130943 Bicyclic inhibitors of MEK and methods of use thereof |
06/16/2005 | US20050130941 Methods of treating alzheimer's disease |
06/16/2005 | US20050130910 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents; drug screening |
06/16/2005 | US20050127823 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same |
06/16/2005 | CA2857067A1 Tubulin inhibitors |
06/16/2005 | CA2549242A1 Hydroxamic acid esters and pharmaceutical use thereof |
06/16/2005 | CA2547887A1 Protein modifier production inhibitor |
06/16/2005 | CA2547556A1 Developments in biologically active methylene blue derivatives (2) |
06/16/2005 | CA2547356A1 Diamine and iminodiacetic acid hydroxamic acid derivatives |
06/16/2005 | CA2546657A1 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
06/16/2005 | CA2545425A1 Azole-based kinase inhibitors |
06/16/2005 | CA2545422A1 Tubulin inhibitors |
06/15/2005 | EP1541563A1 Ccr4 antagonist and medicinal use thereof |
06/15/2005 | EP1541560A1 Novel tetrahydroquinoline derivatives |
06/15/2005 | EP1541559A1 5-substituted isoquinoline derivative |
06/15/2005 | EP1541558A1 Heterocyclic compound having hiv integrase inhibitory activity |
06/15/2005 | EP1541551A1 2-cyano-4-fluoropyrrolidine derivative or its salt |
06/15/2005 | EP1541148A1 Dpp-iv inhibitors |
06/15/2005 | EP1541143A1 Dpp-iv inhibitors |
06/15/2005 | EP1539766A1 Calcitonin gene related peptide receptor antagonists |
06/15/2005 | EP1539754A2 Benzimidazole quinolinones and uses thereof |
06/15/2005 | EP1539749A2 Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators |
06/15/2005 | EP1539748A1 2-phenylpyridin-4-yl derivatives as alk5 inhibitors |
06/15/2005 | EP1539747A1 N-aroyl cyclic amines as orexin receptor antagonists |
06/15/2005 | EP1539743A1 Pyrazole derivatives as gnrh inhibitors |
06/15/2005 | EP1539742A1 Indole derivatives useful as histamine h3 antagonists |
06/15/2005 | EP1539741A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
06/15/2005 | EP1539740A1 Sulphonamide derivatives and their use as tace inhibitors |
06/15/2005 | EP1539739A1 Piperidinyl compounds that selectively bind integrins |
06/15/2005 | EP1539738A1 Novel aryl- 4-halo-4- heteroarylmethylamino)-methyl]-piperidin-1-yl -methanone derivatives, methods for production and use thereof as medicaments |
06/15/2005 | EP1539737A1 Aroyl-piperidine derivatives |